382 results on '"Saletu, Bernd"'
Search Results
102. Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment
103. Placebo-Controlled Sleep Laboratory Studies on the Acute Effects of Zolpidem on Objective and Subjective Sleep and Awakening Quality in Nonorganic Insomnia Related to Neurotic and Stress-Related Disorder
104. SLEEP DISORDERS IN PSYCHIATRY AND THEIR TREATMENT.
105. RECENT ADVANCES IN SLEEP RESEARCH.
106. Artifact Processing in Computerized Analysis of Sleep EEG – A Review
107. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA)
108. Electrical Sources of P300 Event-Related Brain Potentials Revealed by Low Resolution Electromagnetic Tomography
109. Sleep quality during alcohol withdrawal with bright light therapy
110. Nonorganic Insomnia in Generalized Anxiety Disorder
111. Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes
112. Sudden Arousals From Slow Wave Sleep and Panic Disorder: Successful Treatment With Anticonvulsants—A Case Report
113. Testing Drugs for Impaired Brain Function in Old Age: On the Effects of a Single Dose of Bifemelane using Topographic Mapping of EEG and Event-Related Potentials (P300) and Psychometric Measurements in Healthy Elderly Subjects
114. Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls
115. L-11 Quantitatively analyzed EEG/EEG mapping in diagnosis and treatment of dementias
116. PS-62-6 EEG mapping in generalized anxiety disorder
117. Insomnia in Generalized Anxiety Disorder: Polysomnographic, Psychometric and Clinical Investigations before, during and after Therapy with a Long- versus a Short-Half-Life Benzodiazepine (Quazepam versus Triazolam)
118. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women
119. Treatment of the Alcoholic Organic Brain Syndrome: Double-Blind, Placebo-Controlled Clinical, Psychometric and Electroencephalographic Mapping Studies with Modafinil
120. Restriction to a Limited Set of EEG-Target Variables May Lead to Misinterpretation of Pharmaco-EEG Results
121. EEG Mapping and psychopharmacological studies with denbufylline in SDAT and MID
122. Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacology
123. Sleep Laboratory Studies on the Single-Dose Effects of Serotonin Reuptake Inhibitors Paroxetine and Fluoxetine on Human Sleep and Awakening Qualities
124. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms
125. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
126. Propentofylline in Adult-Onset Cognitive Disorders: Double-Blind, Placebo-Controlled, Clinical, Psychometric and Brain Mapping Studies
127. Topographic Mapping of Cognitive Event-Related Potentials in a Double-Blind, Placebo-Controlled Study with the Hemoderivative Actovegin in Age-Associated Memory Impairment
128. On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies
129. Sleep microstructure and neurodegeneration as measured by [123I]ß-CIT SPECT in treated patients with Parkinson’s disease.
130. Brain Regions Activated during an Auditory Discrimination Task in Insomniac Postmenopausal Patients before and after Hormone Replacement Therapy: Low-Resolution Brain Electromagnetic Tomography Applied to Event-Related Potentials.
131. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen–progestogen combination (Climodien[sup ®] , Lafamme[sup ®] ) versus estrogen alone
132. Quality of life in nonorganic and organic sleep disorders: II.Correlation with objective and subjective quality of sleep and awakening.
133. Quality of life in nonorganic and organic sleep disorders: I.Comparison with normative data.
134. Electrical Sources of P300 Event-Related Brain Potentials Revealed by Low Resolution Electromagnetic Tomography.
135. Technetium-99m-HMPAO SPECT Imaging of Cerebral Blood Flow during REM Sleep in Narcoleptics.
136. Cerebral Function in Hyperthyroid Patients.
137. The Evoked Potential in Pharmacopsychiatry.
138. Scalp Topography of the Spontaneous K-Complex and of Delta-Waves in Human Sleep
139. Double-blind, Placebo-controlled Psychometric Studies on the Effects of a Combined Estrogen-progestin Regimen versus Estrogen Alone on Performance, Mood and Personality of Menopausal Syndrome Patients
140. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin
141. 19th biennial IPEG Meeting
142. Spontaneous and drug-induced remission of alcoholic organic brain syndrome: Clinical, psychometric, and neurophysiological studies
143. Determination of pharmacodynamics of psychotropic drugs by psychometric analysis
144. Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations
145. Is the subjectively experienced quality of sleep related to objective sleep parameters?
146. Assessment of psychoactivity and pharmacodynamics of a cerebral vasodilating hexobendine-combination by quantitative electroencephalographic and psychometric analyses
147. Nocturnal Traffic Noise, Sleep, and Quality of Awakening: Neurophysiologic, Psychometric, and Receptor Activity Changes after Quazepam
148. Acoustical Signal Properties for Cardiac/Respiratory Activity and Apneas.
149. Proactive telemedicine monitoring of sleep apnea treatment improves adherence in people with stroke- a randomized controlled trial (HOPES study).
150. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.